ARA160 Antibodies

Santa Cruz Biotechnology provides a broad selection of ARA160 monoclonal antibodies for research applications. ARA160 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ARA160, also known as the androgen receptor coactivator, plays a crucial role in the regulation of androgen receptor signaling, influencing gene expression and cellular responses to androgens. Understanding ARA160's function is particularly important in prostate cancer and other androgen-related diseases. Research with ARA160 monoclonal antibodies enables detailed examination of androgen receptor pathways and their role in disease progression. Scientists can explore the molecular interactions between ARA160 and associated proteins to uncover new therapeutic targets. Advanced research using ARA160 monoclonal antibodies from Santa Cruz Biotechnology continues to expand our understanding of androgen-dependent cellular processes, supporting the development of more effective treatments for hormone-related disorders.